Research vs Standard Consent

Choosing the right document type is critical to establishing proper legal and clinical boundaries. While standard consent types are optimized for single-patient procedures, Research Consent is built specifically to handle the complexities of multi-center clinical trials, pharmaceutical investigations, and large-scale cohort studies.

Understanding these distinctions helps clinical trial coordinators, principal investigators, and site administrators select the correct workflow and satisfy ethical board regulations.

Selecting a Research Consent (instead of standard formats like General Consent or informed procedural consent) reconfigures the platform’s core operational logic:

Research Mode Activation: The document is marked as an active clinical trial protocol under international clinical trial guidelines (such as ICH E6 GCP).
Role Re-binding: The system changes default signer roles to align with clinical research. The document owner is designated as the Principal Investigator (PI), and subjects are designated as Study Participants or Subjects.
Enforced Security Baseline: Automatically enforces FIDO2/WebAuthn biometric passkeys and unique individual Access PINs for all participants, meeting FDA 21 CFR Part 11 electronic signature compliance thresholds.
Workflow Downstream Adaptations: Downstream steps in the builder dashboard are adapted for large-scale enrollment, bypassing manual entry of patient-by-patient rosters during setup and unlocking the enrollment manifest.

How does the participant enrollment model differ?

The most significant difference between Research Consent and standard consent lies in how participants (subjects) are registered and onboarded:

How are standard consents initiated?

For surgical or outpatient procedures (such as standard Informed Consent), coordinators manage participants manually. For details on how informed consent differs clinically and legally from implied consent, see the Informed Consent vs. Implied Consent Guide.

The coordinator enters the specific patient’s name and email in the setup dashboard.
The coordinator manually assigns a unique PIN and dispatches an invitation link directly to that specific patient.
This creates a single, dedicated document instance bound to that one individual from the start.

How are Research Consents initiated?

For clinical trials treating dozens or hundreds of patients, manual patient-by-patient entry is inefficient. Research Consent replaces this with an automated Lazy Enrollment Portal:

The Enrollment Manifest: Instead of manual entry, coordinators pre-compile a single Enrollment Manifest containing all pre-allocated study participant details (such as names, emails, and individual secret access codes). This manifest can be uploaded as a CSV file or entered via an interactive grid in the builder.
Self-Enrollment Handoff: The coordinator registers the principal investigators and trial witnesses in the builder, but does not pre-create individual patient documents.
The Master Link: Finalizing the setup generates a single Master Enrollment Link (a universal portal URL) for all trial participants.
On-the-Fly Document Generation: When a participant visits this portal, the system dynamically creates a private, secure instance of the study consent template for that individual only after they pass verification.

How does the participant identity verification gateway operate?

Because clinical trials are heavily regulated, Research Consent implements a rigorous Double-Lock Gateway for all self-enrolling participants. No one is ever asked to enter a “Patient ID” or navigate a complex registry:

Lock 1 (Email Verification): The participant enters their registered email address. The portal scans the Enrollment Manifest to verify that the email belongs to an authorized trial participant. If verified, the system dispatches a temporary 6-digit verification code (OTP) to that email. The participant must enter this code to verify their access channel.
Lock 2 (Individual Access PIN): Once the email is verified, the participant must enter their unique individual secret access code (the secret PIN pre-allocated to them in the Enrollment Manifest).
Automatic Role Assignment: The system automatically resolves their identity and specific role (e.g., Subject, Guardian, Legally Authorized Representative) from the manifest row. It then instantiates their unique, forensically isolated signing document on-the-fly.
Flexible Circle of Care Rules: If a participant’s row in the manifest does not require an LAR or Guardian (for example, an adult who signs for themselves), those optional fields are simply left empty. The platform dynamically hides the irrelevant signature blocks, generating a perfectly tailored document for that individual.

How do signing limits and lifetimes differ between participants and clinical staff?

To accommodate the realities of clinical trials, the platform applies different expiration timelines and access routes based on the signer’s role:

Subject-Side Signers: Access tokens generated for subjects, guardians, and legal reps have a strict 72-hour lifetime to ensure prompt action and prevent stale sessions.
Clinical/Institutional Signers: Principal Investigators and clinical witnesses receive dedicated, separate signing portals. Because investigators must co-sign many enrolled forms over the course of a trial, their access links have a 5-year lifetime matching the active lifecycle of the trial.

When are QR codes generated for trial signing?

Coordinators often ask if a QR code is generated for every trial. QR codes are strictly optional and are generated only when co-located signing is explicitly enabled:

Bedside/In-Clinic Toggling: In Step 7 of the Intake Wizard (or via the builder’s Settings panel), coordinators can toggle Same-Room Bedside Signing.
Co-located Room Session: When enabled, the platform creates a secure, temporary parallel room session upon deployment.
Master QR Rendering: Only then does the coordinator dashboard render a Master QR Code on the clinic terminal. When scanned by co-located participants, it opens a secure local room session for parallel or hand-off signing.
Standard Trials: If Same-Room Bedside Signing is kept disabled, no QR codes are generated. Participants simply receive their digital invitations or access the universal portal via the Master Enrollment Link.

When a clinical trial coordinator clicks “Complete Setup” on a finalized Research Consent template:

Forensic Template Locking: The master study template is locked and given an immutable cryptographic SHA-256 validation seal. It can no longer be edited, ensuring that every participant signs the exact same version of the protocol.
Master Link Activation: The universal self-enrollment portal becomes live, allowing participants to verify their identity and start self-enrolling.
Investigator Notifications: The system prepares automated notification queues, alerting investigators immediately when a participant completes their signature so the clinical team can review, co-sign, and finalize the forensic record.